Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Virbac Corporation - Financial and Strategic Analysis Review

Global Markets Direct
April 21, 2009
17 Pages - Pub ID: GMD2221943
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Virbac Corporation - Financial and Strategic Analysis Review

Summary

Virbac Corporation (Virbac) is a subsidiary of Virbac Group. It is principally engaged in manufacture and marketing of animal health and pet care products. The company provides dermatological, parasiticide, and dental products for vets. The company carries out its operations through two business segments namely veterinary and consumer. Through its veterinary segment, the company is involved in manufacturing and distribution of pet health products mainly to veterinarian offices. In addition, some of the company products are manufactured and distributed under license from Virbac (VBSA), a French veterinary pharmaceutical manufacturer.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Virbac Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct’s views on the company.Scope
  • The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
  • A quick “one-stop-shop” to understand the company.
  • Enhance business/sales activities by understanding customers’ businesses better.
  • Get detailed information and financial & strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitors’ weaknesses and target the market opportunities available to them.
  • Compare your company’s financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Related Reports:
GlaxoSmithKline (GSK) Profile & Health Care Industry Trends Analysis 2010
Novartis (NVS) Profile & Health Care Industry Trends Analysis 2010
AmerisourceBergen (ABC) Profile & Health Care Industry Trends Analysis 2010
Roche Holding LTD (RHHBY) Profile & Health Care Industry Trends Analysis 2010
Merck & Co Inc. (MRK) Profile & Biotech Industry Trends Analysis 2010
Eli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 2010
Pfizer Inc (PFE) Profile & Biotech Industry Trends Analysis 2010
Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010
Johnson & Johnson (JNJ) Profile & Biotech Industry Trends Analysis 2010
Merck & Co. Performance, Products, Pipeline and Potential

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 4